Genesis Agrees to Pay $21 Million Penalty to Settle SEC Charges
The Securities and Exchange Commission today announced that Genesis Global Capital, LLC agreed to...

SEC Charges Advisory Firm HG Vora for Disclosure Failures Ahead of Ryder Acquisition Bid
The Securities and Exchange Commission today announced settled charges against New York-based inv...

SEC Small Business Advisory Committee to Discuss the Accredited Investor Definition and the State of the IPO Market
The Securities and Exchange Commission’s Small Business Capital Formation Advisory Committee toda...

SEC Proposes Rule to Update Definition of Qualifying Venture Capital Funds
The Securities and Exchange Commission today proposed a rule that would update the dollar thresho...

How sterile pharma manufacturers can grow capacity without capital investment
The world will need more sterile products than manufacturers have or can build capacity for. But they can create capacity and take market share by running higher volumes through their existing lines.

Powered by Feed Informer